|
1
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang H, Yu J, Wang L, Ding D, Zhang L, Chu
C, Chen Q, Xu Z, Zou Q and Liu X: miR-320a is an independent
prognostic biomarker for invasive breast cancer. Oncol Lett.
8:1043–1050. 2014.PubMed/NCBI
|
|
4
|
Tejero R, Navarro A, Campayo M, Viñolas N,
Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L,
Ramirez J, et al: miR-141 and miR-200c as markers of overall
survival in early stage non-small cell lung cancer adenocarcinoma.
PLoS One. 9:e1018992014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chou J, Lin JH, Brenot A, Kim JW, Provot S
and Werb Z: GATA3 suppresses metastasis and modulates the tumour
microenvironment by regulating microRNA-29b expression. Nat Cell
Biol. 15:201–213. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang T, Liang Y, Lin Q, Liu J, Luo F, Li
X, Zhou H, Zhuang S and Zhang H: miR-29 mediates TGFβ1-induced
extracellular matrix synthesis through activation of PI3K-AKT
pathway in human lung fibroblasts. J Cell Biochem. 114:1336–1342.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park SY, Lee JH, Ha M, Nam JW and Kim VN:
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat
Struct Mol Biol. 16:23–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pandey M, Sultana S and Gupta KP:
Involvement of epigenetics and microRNA-29b in the urethane induced
inception and establishment of mouse lung tumors. Exp Mol Pathol.
96:61–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao XY, Ma HX, Shang YH, Jin MS, Kong F,
Jia ZF, Cao DH, Wang YP, Suo J and Jiang J: DNA methyltransferase3a
expression is an independent poor prognostic indicator in gastric
cancer. World J Gastroenterol. 20:8201–8208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ibrahem L, Mahfouz R, Elhelw L, Abdsalam
EM and Soliman R: Prognostic significance of DNMT3A mutations in
patients with acute myeloid leukemia. Blood Cells Mol Dis.
54:84–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Niederwieser C, Kohlschmidt J, Volinia S,
Whitman SP, Metzeler KH, Eisfeld AK, Maharry K, Yan P, Frankhouser
D, Becker H, et al: Prognostic and biologic significance of DNMT3B
expression in older patients with cytogenetically normal primary
acute myeloid leukemia. Leukemia. 29:567–575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu CH, Peng KL, Kang ML, Chen YR, Yang
YC, Tsai CH, Chu CS, Jeng YM, Chen YT, Lin FM, et al: TET1
suppresses cancer invasion by activating the tissue inhibitors of
metalloproteinases. Cell Reports. 2:568–579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun M, Song CX, Huang H, Frankenberger CA,
Sankarasharma D, Gomes S, Chen P, Chen J, Chada KK, He C, et al:
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth
and metastasis. Proc Natl Acad Sci USA. 110:9920–9925. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu HG, Zhan W, Yan L, Qin RY, Yan YP, Yang
ZJ, Liu GC, Li GQ, Wang HF, Li XL, et al: TET1 partially mediates
HDAC inhibitor-induced suppression of breast cancer invasion. Mol
Med Rep. 10:2595–2600. 2014.PubMed/NCBI
|
|
15
|
Xu X, Yu T, Shi J, Chen X, Zhang W, Lin T,
Liu Z, Wang Y, Zeng Z, Wang C, et al: Thymine DNA glycosylase is a
positive regulator of Wnt signaling in colorectal cancer. J Biol
Chem. 289:8881–8890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morita S, Horii T, Kimura M, Ochiya T,
Tajima S and Hatada I: miR-29 represses the activities of DNA
methyltransferases and DNA demethylases. Int J Mol Sci.
14:14647–14658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goldhirsch A, Wood WC, Senn HJ, Glick JH
and Gelber RD: International Consensus Panel on the Treatment of
Primary Breast Cancer: Fifth International Conference on Adjuvant
Therapy of Breast Cancer, St Gallen, March 1995. Eur J Cancer.
31A:1754–1759. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ota D, Mimori K, Yokobori T, Iwatsuki M,
Kataoka A, Masuda N, Ishii H, Ohno S and Mori M: Identification of
recurrence-related microRNAs in the bone marrow of breast cancer
patients. Int J Oncol. 38:955–962. 2011.PubMed/NCBI
|
|
19
|
Vergoulis T, Vlachos IS, Alexiou P,
Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N,
Dalamagas T and Hatzigeorgiou AG: TarBase 6.0: Capturing the
exponential growth of miRNA targets with experimental support.
Nucleic Acids Res. 40:(D1). D222–D229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song SJ, Poliseno L, Song MS, Ala U,
Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, et al:
MicroRNA-antagonism regulates breast cancer stemness and metastasis
via TET-family-dependent chromatin remodeling. Cell. 154:311–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
da Costa NM, Hautefeuille A, Cros MP,
Melendez ME, Waters T, Swann P, Hainaut P and Pinto LF:
Transcriptional regulation of thymine DNA glycosylase (TDG) by the
tumor suppressor protein p53. Cell Cycle. 11:4570–4578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ng EK, Li R, Shin VY, Siu JM, Ma ES and
Kwong A: MicroRNA-143 is downregulated in breast cancer and
regulates DNA methyltransferases 3A in breast cancer cells. Tumour
Biol. 35:2591–2598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu Z, Xiao Q, Zhao L, Ren J, Bai X, Sun M,
Wu H, Liu X, Song Z, Yan Y, et al: DNA methyltransferase 1/3a
overexpression in sporadic breast cancer is associated with reduced
expression of estrogen receptor-alpha/breast cancer susceptibility
gene 1 and poor prognosis. Mol Carcinog. Jan 25–2014.(Epub ahead of
print). View Article : Google Scholar
|
|
24
|
Starlard-Davenport A, Kutanzi K, Tryndyak
V, Word B and Lyn-Cook B: Restoration of the methylation status of
hypermethylated gene promoters by microRNA-29b in human breast
cancer: A novel epigenetic therapeutic approach. J Carcinog.
12:152013. View Article : Google Scholar : PubMed/NCBI
|
